19.96%SPY 79.52 
5.39%XLF 9.68 3.09%
Digg
Del.icio.us
Newsvine 
Facebook
Stumbleupon
PRINCETON, N.J. - Covance Inc. and WuXi Pharmatech announced Monday they are abandoning plans to build a joint venture for preclinical contract research services in China.
Drug development services provider Covance and WuXi Pharmatech, a pharmaceutical, biotechnology and medical device research and development outsourcing company, gave no reason for abandoning the 50-50 venture.
WuXi said it will move on its original plan to build a 323,450-square-foot facility in Suzhou, China, that is due to open in the second half of 2009. The building will be used to offer preclinical services and toxicology work.
China's bid to establish its own next generation mobile phone technology standard got a boost from the world's biggest cell phone maker...
U.S stocks fell on Wednesday as investors grew concerned that a bailout loan package for ailing automakers would fail to be approved by U.S. lawm...
Palestinian President Mahmoud Abbas says Israel will free 250 prisoners as a goodwill gesture before an upcoming Muslim holiday. Abbas said at a ...
Baldwin Linguas:
Translations Interpreting Localization:
English French Portuguese Spanish
Get your next web design project done with our los angeles web design team - Best web design with great price.
Split Big Profits! You Find it & We Fund it! Co-Own Or Cash Out! Get Free Info Kit Now!
Partners   
|
© 2008 The Ibtimes Company. All Rights Reserved. Terms of service | Privacy Policy | Advertising | About Us | Contact Us | Archives
EMAIL
PRINT
RSS
SHARE
2.18
-0.31
